HCK |
IPI00029769 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
59.640 |
Evidence |
O
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
59.640 |
Evidence |
O
|
TP53 |
TP53, P53: Cellular tumor antigen p53 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
59.630 |
Evidence |
|
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
59.630 |
Evidence |
|
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
TOP2A |
TOP2A, TOP2: DNA topoisomerase 2-alpha |
59.630 |
Evidence |
|
MET |
MET: Hepatocyte growth factor receptor precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
59.540 |
Evidence |
|
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
59.540 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
59.540 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
59.540 |
Evidence |
|
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
59.540 |
Evidence |
|
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
59.540 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
RXRA |
RXRA, NR2B1: Retinoic acid receptor RXR-alpha |
59.5 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
59.5 |
Evidence |
|
SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
MBL2 |
MBL2, MBL: Mannose-binding protein C precursor |
59.270 |
Evidence |
|
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
59.270 |
Evidence |
|
F9 |
F9: Coagulation factor IX precursor |
C8G |
C8G: Complement component C8 gamma chain precursor |
59.270 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
59.050 |
Evidence |
|
KIAA0788 |
ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase |
LSM3 |
LSM3, MDS017: U6 snRNA-associated Sm-like protein LSm3 |
59.010 |
Evidence |
|
KIAA0788 |
ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase |
LSM5 |
LSM5: U6 snRNA-associated Sm-like protein LSm5 |
59.010 |
Evidence |
|
NUTF2 |
NUTF2, NTF2: Nuclear transport factor 2 |
NUP153 |
IPI00514528 |
58.980 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
58.920 |
Evidence |
|
LSM3 |
LSM3, MDS017: U6 snRNA-associated Sm-like protein LSm3 |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
58.920 |
Evidence |
|
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
LSM5 |
LSM5: U6 snRNA-associated Sm-like protein LSm5 |
58.920 |
Evidence |
|
EIF3S2 |
EIF3S2, TRIP1: Eukaryotic translation initiation factor 3 subunit 2 |
LSM5 |
LSM5: U6 snRNA-associated Sm-like protein LSm5 |
58.920 |
Evidence |
|
LSM8 |
LSM8: U6 snRNA-associated Sm-like protein LSm8 |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
58.920 |
Evidence |
|